SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

20 hedge funds and large institutions have $671K invested in Salarius Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$18.8K
2
+$4.2K

Top Sellers

1
-$45.1K
2
-$35K
3
-$34.2K
4
VF
Virtu Financial
New York
-$17K
5
TRCT
Tower Research Capital (TRC)
New York
-$11.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$264K
2
$124K
3
$80K
4
$60K
5
$28K
6
$23K
7
$17K
8
$13K
9
$12K
10
$8K
11
$8K
12
$7K
13
$6K
14
$6K
15
$5K
16
$4K
17
$2K
18
$2K
19
$2K
20
–
21
–
22
–
23
–